You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

CLINICAL TRIALS PROFILE FOR BARUSIBAN

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Barusiban

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00587327 ↗	Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions	Completed	Ferring Pharmaceuticals	Phase 2	The main purpose of this clinical research trial was to evaluate the effects of barusiban and atosiban compared to placebo on luteal phase uterine contractions in oocyte donors supplemented with progesterone.
NCT01043120 ↗	Effect of Oxytocin Antagonist on Reduction of Uterine Contractions	Completed	Ferring Pharmaceuticals	Phase 2	The main purpose of this clinical research trial was to evaluate the effects of barusiban compared to placebo on uterine contractions on luteal phase uterine contractions in oocyte donors supplemented with progesterone.
NCT01723982 ↗	Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions	Completed	Ferring Pharmaceuticals	Phase 2	This trial investigates the effects of FE 200440 compared to placebo on implantation rate in women undergoing IVF/ICSI treatment
NCT02725736 ↗	Tocolytic Therapy for Preterm Labor in Multiple Gestation	Unknown status	Tel-Aviv Sourasky Medical Center	Phase 3	To compare the tocolytic efficacy oxytocin receptor antagonist (Atosiban) with that of calcium channel blockers (Nifedipine) among women with multiple gestation who present with threatened preterm labor.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Barusiban

Condition Name

Chart
Table

Condition Name for
Intervention	Trials
In Vitro Fertilisation (IVF) Treatment	2
In Vitro Fertilisation (IVF) Treatment.	2
Infertility	1
Labor Preterm Multiple	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for
Intervention	Trials
Premature Birth	1
Obstetric Labor, Premature	1
Infertility	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Barusiban

Trials by Country

Map
Table

Trials by Country for
Location	Trials
Czech Republic	3
Belgium	3
Spain	3
Czechia	2
Australia	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Barusiban

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	3
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Barusiban

Sponsor Name

Chart
Table

Sponsor Name for
Sponsor	Trials
Ferring Pharmaceuticals	3
Tel-Aviv Sourasky Medical Center	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for
Sponsor	Trials
Industry	3
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.